Mo1876 TREATMENT PERSISTENCE AND MAINTENANCE DOSING FOR USTEKINUMAB AND ADALIMUMAB AMONG PATIENTS WITH CROHN'S DISEASE WITH TWO-YEARS FOLLOW-UP IN THE SYMPHONY HEALTH DATABASE